Top upgrades and downgrades on 3/16

Analysts Notebook wrote a column · Mar 16, 2022 19:32

Upgrades

• $ACADIA Pharmaceuticals (ACAD.US)$: Canaccord Genuity Upgrades to Buy from Hold - PT $31 (from $30)

• $Host Hotels & Resorts (HST.US)$: Raymond James Upgrades to Outperform from Market Perform - PT $21

• $Magna International (MGA.US)$: Raymond James Upgrades to Market Perform from Underperform - PT $68

• $Micron Technology (MU.US)$: Bernstein Upgrades to Outperform from Market Perform - PT $94 (from $58)

• $Ultragenyx Pharmaceutical (RARE.US)$: Credit Suisse Upgrades to Outperform from Neutral - PT $105 (from $99)

• $Starbucks (SBUX.US)$: JPMorgan Upgrades to Overweight from Neutral - PT $101

• $Wingstop (WING.US)$: Northcoast Research Upgrades to Buy from Neutral

Downgrades

• $Entasis Therapeutics (ETTX.US)$: Alliance Global Partners Downgrades to Neutral from Buy - PT $2

• $SoFi Technologies (SOFI.US)$: Morgan Stanley Downgrades to Equalweight from Overweight - PT $10 (from $18)

Initiations

• $Constellation Energy (CEG.US)$: Morgan Stanley initiates at Overweight - PT $63

• $SpartanNash (SPTN.US)$: Craig-Hallum initiates at Buy - PT $19

• $HF Sinclair (DINO.US)$: JPMorgan initiates at Neutral - PT $36

• $Inhibrx (INBX.US)$: SMBC Nikko Securities initiates at Outperform - PT $40

• $Jounce Therapeutics (JNCE.US)$: SMBC Nikko Securities initiates at Outperform - PT $17

Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only. Read more

Translate

Report

346K Views

Comment

Moomoo News Official Account

How do analysts evaluate the market?

19K

Followers

Following

39K

Visitors